Frontiers | NF-κB Inducing Kinase Regulates Intestinal Immunity and Homeostasis
NIK as a Druggable Mediator of Tissue Injury: Trends in Molecular Medicine
Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study | Signal Transduction and Targeted Therapy
Expression of Nik-related kinase in smooth muscle cells attenuates vascular inflammation and intimal hyperplasia - Figure f3 | Aging
Pharmacological inhibition of NF-κB-inducing kinase (NIK) with small molecules for the treatment of human diseases - RSC Medicinal Chemistry (RSC Publishing) DOI:10.1039/D0MD00361A
RS, reactive species; NF-kB, nuclear factor kappa B; NIK,... | Download Scientific Diagram
Frontiers | The Therapeutic Potential of Targeting NIK in B Cell Malignancies
IJMS | Free Full-Text | Targeting NF-κB-Inducing Kinase (NIK) in Immunity, Inflammation, and Cancer
Structure-Based Design of Tricyclic NF-κB Inducing Kinase (NIK) Inhibitors That Have High Selectivity over Phosphoinositide-3-kinase (PI3K) | Journal of Medicinal Chemistry
Non-canonical NF-κB signaling pathway | Cell Research
NF-κB inducing kinase: A key regulator in the immune system and in cancer - ScienceDirect
Recombinant human NFkB Inducing Kinase NIK protein (ab105210) | Abcam
NF-κB Inducing Kinase, NIK Mediates Cigarette Smoke/TNFα-Induced Histone Acetylation and Inflammation through Differential Activation of IKKs | PLOS ONE
NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus | Nature Communications
Anti-NFkB Inducing Kinase NIK antibody (ab228587) | Abcam
Nik‐related kinase is targeted for proteasomal degradation by the chaperone‐dependent ubiquitin ligase CHIP - Naito - 2020 - FEBS Letters - Wiley Online Library
The discovery of quinoline derivatives, as NF-κB inducing kinase (NIK) inhibitors with anti-inflammatory effects in vitro, low toxicities against T cell growth - ScienceDirect
Functional interplay between NF-κB-inducing kinase and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma | Haematologica
Kinases as Novel Therapeutic Targets in Asthma and Chronic Obstructive Pulmonary Disease | Pharmacological Reviews
The non-canonical NF-κB pathway in immunity and inflammation | Nature Reviews Immunology
IJMS | Free Full-Text | Targeting NF-κB-Inducing Kinase (NIK) in Immunity, Inflammation, and Cancer
NHRI researchers report expression of Nik-related kinase in smooth muscle cells attenuates vascular inflammation and intimal hyperplasia – NHRI Communications
